City of Hope opens CAR T trial for HER2 breast cancer patients with brain metastases

(City of Hope) Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge. A new City of Hope chimeric antigen receptor (CAR) T cell trial -- the first to focus on HER2-postive breast cancer patients with brain metastases -- is now enrolling potential participants.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news